Plantarc Bio Ltd (PLNT) - Total Liabilities

Latest as of June 2025: ILA777.00K ILA ≈ $2.08K USD

Based on the latest financial reports, Plantarc Bio Ltd (PLNT) has total liabilities worth ILA777.00K ILA (≈ $2.08K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is Plantarc Bio Ltd growing its equity to track the company's year-over-year net asset growth rate.

Plantarc Bio Ltd - Total Liabilities Trend (2018–2024)

This chart illustrates how Plantarc Bio Ltd's total liabilities have evolved over time, based on quarterly financial data. See Plantarc Bio Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Plantarc Bio Ltd Competitors by Total Liabilities

The table below lists competitors of Plantarc Bio Ltd ranked by their total liabilities.

Company Country Total Liabilities
Medigene AG
XETRA:MDG1
Germany €9.15 Million
Alliance Mining Corp
V:ALM
Canada CA$3.73 Million
Copper Lake Resources Ltd
V:CPL
Canada CA$1.91 Million
Capella Minerals Ltd
V:CMIL
Canada CA$1.84 Million
Totalindo Eka Persada Tbk PT
JK:TOPS
Indonesia Rp1.21 Trillion
Helios Underwriting PLC
LSE:HUW
UK GBX69.89 Million

Liability Composition Analysis (2018–2024)

This chart breaks down Plantarc Bio Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Plantarc Bio Ltd (PLNT) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 10.51 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.10 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.09 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Plantarc Bio Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Plantarc Bio Ltd (2018–2024)

The table below shows the annual total liabilities of Plantarc Bio Ltd from 2018 to 2024.

Year Total Liabilities Change
2024-12-31 ILA1.41 Million
≈ $3.79K
+15.05%
2023-12-31 ILA1.23 Million
≈ $3.29K
-24.60%
2022-12-31 ILA1.63 Million
≈ $4.37K
+63.16%
2021-12-31 ILA999.00K
≈ $2.68K
+3.63%
2020-12-31 ILA964.00K
≈ $2.58K
+50.63%
2019-12-31 ILA640.00K
≈ $1.72K
+46.79%
2018-12-31 ILA436.00K
≈ $1.17K
--

About Plantarc Bio Ltd

TA:PLNT Israel Biotechnology
Market Cap
$1.96 Million
ILA731.02 Million ILA
Market Cap Rank
#30023 Global
#442 in Israel
Share Price
ILA220.90
Change (1 day)
+0.00%
52-Week Range
ILA186.60 - ILA224.40
All Time High
ILA1827.00
About

PlantArc Bio Ltd. operates as an Ag-Bio company for the crop protection and yield enhancement. The company develops and operates a Direct-In-Plant gene discovery platform. It focuses on yield improvement, drought resistance, and herbicide and insects tolerance. The company was incorporated in 2014 and is based in Ra'anana, Israel.